DNA damage in children treated with imipramine for primary nocturnal enuresis

Pediatrics International

Volumn 44, Issue 6, 2002, Pages 617-621

  Dündaröz, Ruşen ^a   Türkbay, Tümer ^a   Sürer, Ilhami ^a   Gök, Faysal ^a   Denli, Metin ^a   Baltaci, Volkan ^a  

^a NONE   (Turkey)

Author keywords

Comet assay; DNA damage; Imipramine; Mutagenicity; Primary nocturnal enuresis

Indexed keywords

IMIPRAMINE;

ADOLESCENT; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG USE; FEMALE; HUMAN; LYMPHOCYTE MIGRATION; MALE; NOCTURNAL ENURESIS; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; CHILD; COMET ASSAY; DNA; DNA DAMAGE; ENURESIS; FEMALE; HUMANS; IMIPRAMINE; LYMPHOCYTES; MALE; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 0036433087     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2002.01647.x     Document Type: Article

References (35)

1. Mark SD, Frank JD. Nocturnal enuresis. Br. J. Urol. 1995; 75: 427-34.
2. Rushton HG. Older pharmacologic therapy for nocturnal enuresis. Clin. Pediatr. (Phila.) 1993; 31: 10-13.
3. Rushton HG. Wetting and functional voiding disorders. Urol. Clin. North Am. 1995; 22: 75-93.
4. Puri VN. Increased urinary antidiuretic hormone excretion by imipramine. Exp. Clin. Endocrinol. 1986; 88: 112-14.
5. Kardash S, Hillman ES, Werry J. Efficacy of imipramine in childhood enuresis: A double-blind control study with placebo. Can. Med. Assoc. J. 1968; 99: 263-6.
6. Petersen KE, Andersen OO, Hansen T. Mode of action and relative value of imipramine and similar drugs in the treatment of nocturnal enuresis. Eur. J. Clin. Pharmacol. 1974; 7: 187-94.
7. Jorgensen OS, Lober M, Christiansen J, Gram LF. Plasma concentration and clinical effect in imipramine treatment of childhood enuresis. Clin. Pharmacokinet. 1980; 5: 386-93.
8. Gimpel GA, Warzak WJ, Kuhn BR, Walburn JN. Clinical perspectives in primary nocturnal enuresis. Clin. Pediatr. (Phila.) 1998; 37: 23-9.
9. Shaffer D, Costello AJ, Hill ID. Control of enuresis with imipramine. Arch. Dis. Child. 1968; 43: 665-71.
10. Fouron JC, Chicoine R. ECG changes in fatal imipramine (Tofranil) intoxication. Pediatrics 1971; 48: 777-81.
11. Sullivan J, Abrams P. Pharmacological management of incontinence. Eur. Urol. 1999; 36: 89-95.
12. Montanari G, Baraldo M, Zara G, Benetello P, Secchieri S, Furlanut M. Side effects of imipramine therapy in enuretic children. Pharmacol. Res. 1990; 22: 103-4.
13. Shaefer MS, Edmunds AL, Markin RS, Wood RP, Pillen TJ, Shaw BW Jr. Hepatic failure associated with imipramine therapy. Pharmacotherapy 1990; 10: 66-9.
14. Baltaci V, Aygun N, Akyol D, Karakaya AE, Sardas S. Chromosomal aberrations and alkaline comet assay in families with habitual abortion. Mutat. Res. 1998; 417: 47-55.
15. Haque M, Ellerstein NS, Gundy JH et al. Parental perceptions of enuresis. A collaborative study. Am. J. Dis. Child. 1981; 135: 809-11.
16. Moffatt ME. Nocturnal enuresis: Psychologic implications of treatment and nontreatment. J. Pediatr. 1989; 114: 697-704.
17. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretics. Arch. Dis. Child. 1974; 49: 259-63.
18. van Schaik N, Graf U. Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat. Res. 1991; 260: 99-104.
19. Saxena R, Ahuja YR. Genotoxicity evaluation of the tricyclic antidepressants amitriptyline and imipramine using human lymphocyte cultures. Environ. Mol. Mutagen 1988; 12: 421-30.
20. Fu TK, Jarvik LF, Yen FS et al. Effects of imipramine on chromosomes in psychiatric patients. Neuropsychobiology 1978; 4: 113-20.
21. Fu TK, Jarvik LF, Yen FS, Matsuyama SS. In vitro effects of imipramine on proliferation of human leukocytes. Arch. Gen. Psychiatry 1977; 34: 728-30.
22. Fu TK, Jarvik LF. The in vitro effects of imipramine on human chromosomes. Mutat. Res. 1977; 48: 89-94.
23. Balbi A, Muscettola G, Staiano N, Martire G, De Lorenzo F. Psychotropic drugs: Evaluation of mutagenic effect. Pharmacol. Res. Commun. 1980; 12: 423-31.
24. Bignami M, Morpurgo G, Pagliani R, Carere A, Conti G, Di Giuseppe G. Non-disjunction and crossing-over induced by pharmaceutical drugs in Aspergillus nidulans. Mutat. Res. 1974; 26: 159-70.
25. Bishun N, Smith N, Williams DC. Lack of in vivo cytogenetic effects of imipramine in rats. Teratology 1974; 10: 191-2.
26. Sykora I, Gandalovicova D, Rezabek K. Absence of noxious effects of selected neuroleptics in dominant-lethal mutagenesis assay. Mutat. Res. 1979; 66: 291-9.
27. Ostling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA damages in induvidual mammalian cells. Biochem. Biophys. Res. Commun. 1984; 123: 291-8.
28. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in induvidual cells. Exp. Cell. Res. 1988; 175: 184-91.
29. Vodicka P, Bastlova T, Vodickova L, Peterkova K, Lambert B, Heminski K. Biomarkers of styrene exposure in lamination workers; levels of -guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis 1995; 16: 1473-81.
30. Binkova B, Lewtas J, Miskova I et al. Biomarkers studies in the Northern Bohemia. Environ. Health Prespect. 1996; 104: 591-7.
31. Andreoli C, Leopardi P, Crebelli R. Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res. 1997; 377: 95-104.
32. Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn. J. Cancer Res. 2001; 92: 367-76.
33. Cohen L, Marshall GD Jr, Cheng L, Agarwal SK, Wei Q. DNA repair capacity in healthy medical students during and after exam stress. J. Behav. Med. 2000; 23: 531-44.
34. Irie M, Asami S, Nagata S, Miyata M, Kasai H. Classical conditioning of oxidative DNA damage in rats. Neurosci. Lett. 2000; 288: 13-16.
35. Fischman HK, Pero RW, Kelly DD. Psychogenic stress induces chromosomal and DNA damage. Int. J. Neurosci. 1996; 84: 219-27.